LYRA · Categories · Form 4

LYRA - SEC Form 4 insider transactions

Lyra Therapeutics Inc. (LYRA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for LYRA

• 23d
  SEC Form 4 filed by Palasis Maria

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 23d
  SEC Form 4 filed by Cavalier Jason

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 108d
  Chief Financial Officer Cavalier Jason sold $2,587 worth of shares (769 units at $3.36), decreasing direct ownership by 0.15% to 518,547 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 108d
  President & CEO Palasis Maria sold $5,726 worth of shares (1,702 units at $3.36), decreasing direct ownership by 0.15% to 1,096,733 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 164d
  Large owner Perceptive Advisors Llc sold $182,515 worth of shares (45,875 units at $3.98) (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 167d
  Large owner Perceptive Advisors Llc sold $344,219 worth of shares (70,390 units at $4.89) (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 200d
  Amendment: SEC Form 4 filed by President & CEO Palasis Maria

  4/A - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 205d
  SEC Form 4 filed by President & CEO Palasis Maria

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 286d
  President & CEO Palasis Maria sold $13,944 worth of shares (1,565 units at $8.91), decreasing direct ownership by 0.14% to 1,098,435 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 286d
  Chief Financial Officer Cavalier Jason sold $6,094 worth of shares (684 units at $8.91), decreasing direct ownership by 0.13% to 519,316 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 345d
  SEC Form 4 filed by Director Snyderman Nancy Lynn Md

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 345d
  SEC Form 4 filed by Director Smith W Bradford

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 345d
  SEC Form 4 filed by Director Merrifield C Ann

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 345d
  SEC Form 4 filed by Director Tobin James R

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 471d
  President & CEO Palasis Maria was granted 800,000 shares, increasing direct ownership by 267% to 1,100,000 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 471d
  Chief Financial Officer Cavalier Jason was granted 420,000 shares, increasing direct ownership by 420% to 520,000 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 501d
  SEC Form 4 filed by President & CEO Palasis Maria

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 501d
  SEC Form 4 filed by Executive Chair Waksal Harlan

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 555d
  President & CEO Palasis Maria was granted 300,000 shares (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 555d
  Chief Financial Officer Cavalier Jason was granted 100,000 shares (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 681d
  SEC Form 4 filed by Director Tobin James R

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 681d
  SEC Form 4 filed by Director Smith W Bradford

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 681d
  SEC Form 4 filed by Director Snyderman Nancy Lynn Md

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 681d
  SEC Form 4 filed by Director Poukalov Konstantin

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 681d
  SEC Form 4 filed by Director Merrifield C Ann

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 681d
  SEC Form 4 filed by Director Altman Michael Seth

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 767d
  Waksal Harlan was granted 275,000 shares, increasing direct ownership by 105% to 536,966 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 767d
  SEC Form 4 filed by Palasis Maria

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 815d
  SEC Form 4 filed by Bishop John E

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 815d
  SEC Form 4 filed by Nieman Richard

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 815d
  SEC Form 4 filed by Cavalier Jason

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1019d
  SEC Form 4 filed by Palasis Maria (Amendment)

  4/A - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1026d
  SEC Form 4 filed by Tobin James R

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1026d
  SEC Form 4 filed by Smith W Bradford

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1026d
  SEC Form 4 filed by Poukalov Konstantin

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1026d
  SEC Form 4 filed by Merrifield C Ann

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1026d
  SEC Form 4 filed by Altman Michael Seth

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1026d
  SEC Form 4 filed by Snyderman Nancy Lynn Md

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1026d
  SEC Form 4 filed by Anderson Edward T

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1035d
  SEC Form 4 filed by Palasis Maria

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1059d
  SEC Form 4 filed by Nbvm Gp, Llc

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1059d
  SEC Form 4 filed by Anderson Edward T

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1059d
  SEC Form 4 filed by Perceptive Advisors Llc

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1153d
  SEC Form 4 filed by Bishop John E

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1179d
  SEC Form 4: Richard Robert E. was granted 30,000 shares

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1179d
  SEC Form 4 filed by Waksal Harlan

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1179d
  SEC Form 4: Noyes Corinne was granted 36,667 shares

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1179d
  SEC Form 4 filed by Cavalier Jason

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1179d
  SEC Form 4 filed by Palasis Maria

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1179d
  SEC Form 4 filed by Nieman Richard

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1384d
  SEC Form 4 filed by Nieman Richard

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1405d
  SEC Form 4 filed by Altman Michael Seth

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1405d
  SEC Form 4 filed by Merrifield C Ann

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1405d
  SEC Form 4 filed by Smith W Bradford

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1405d
  SEC Form 4 filed by Poukalov Konstantin

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1405d
  SEC Form 4 filed by Anderson Edward T

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1405d
  SEC Form 4 filed by Waksal Harlan

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1405d
  SEC Form 4 filed by Snyderman Nancy Lynn Md

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1413d
  SEC Form 4: Merrifield C Ann bought $20,200 worth of shares (4,000 units at $5.05), increasing direct ownership by 55% to 11,328 units

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1440d
  SEC Form 4: Merrifield C Ann bought $18,486 worth of shares (3,828 units at $4.83), increasing direct ownership by 109% to 7,328 units

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)

Other LYRA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends